EMA validates Daiichi Sankyo-AstraZeneca’s cancer therapy applications

The data underpinning the MAA applications come from the TROPION-Lung01 and TROPION-Breast01 Phase III clinical trials. Credit: Louis Reed on Unsplash.



  • Daiichi Sankyo